Plasma-seq: a novel strategy for metastatic prostate cancer analysis
Date
2013-01-01
Authors
Major Professor
Advisor
Committee Member
Journal Title
Journal ISSN
Volume Title
Publisher
Authors
Person
Trimarchi, Jeffrey
Professor
Research Projects
Organizational Units
Organizational Unit
Journal Issue
Is Version Of
Versions
Series
Department
Genetics, Development and Cell Biology
Abstract
Personalized genomics will only be useful for monitoring the prognosis of patients with cancer when it becomes much more cost-effective and quicker to apply. A recent study brings this closer to reality with the development of plasma-seq, a rapid, low-cost method that sequences the circulating DNA present in the peripheral blood of patients with cancer. The power of this technique is demonstrated with the examination of tumor genomes from patients with prostate cancer.
Comments
This article is from Genome Medicine 5 (2013): 35, doi: 10.1186/gm439. Posted with permission.
Description
Keywords
Citation
DOI
Source
Copyright
Tue Jan 01 00:00:00 UTC 2013